Literature DB >> 19770650

Growth hormone and bone.

Nicholas A Tritos1, Beverly M K Biller.   

Abstract

PURPOSE OF REVIEW: Description of recent progress in our understanding of growth hormone (GH) effects on bone. RECENT
FINDINGS: Growth hormone deficiency is associated with low bone mass in children and adults, in addition to its well established impact on growth. Although GH and insulin-like growth factor I have direct skeletal actions, it is also possible that disordered parathyroid hormone secretion or effect may mediate some of the deleterious consequences of GH deficiency on bone. The benefits of GH replacement on bone mineral density have been demonstrated in many studies, but it remains unclear whether these are consistent across patient subgroups. The impact of GH replacement on fracture risk has not been definitively established. The positive effects of GH administration on growth are well established in childhood-onset growth hormone deficiency, as well as in several other pediatric conditions. Data on investigational uses of GH are also presented.
SUMMARY: GH may have a relevant role in bone physiology and several disease states in addition to growth hormone deficiency. Although the salutary effects of GH replacement on bone growth and bone density are well characterized, additional studies are required to examine the impact of GH replacement on fracture risk as well as potential benefits in osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19770650     DOI: 10.1097/MED.0b013e3283319e6d

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  17 in total

1.  Growth hormone and lactate responses induced by maximal isometric voluntary contractions and whole-body vibrations in healthy subjects.

Authors:  A Sartorio; F Agosti; A De Col; N Marazzi; F Rastelli; S Chiavaroli; C L Lafortuna; S G Cella; A E Rigamonti
Journal:  J Endocrinol Invest       Date:  2010-09-02       Impact factor: 4.256

2.  Potential treatment of hypoparathyroidism with recombinant plasmids encoding preproparathyroid hormone.

Authors:  D Liu; Y Zhu; C Yang; J Long; C Yao; J Li; S Wang
Journal:  J Endocrinol Invest       Date:  2011-09-27       Impact factor: 4.256

3.  Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult-onset growth hormone deficiency - a KIMS database analysis.

Authors:  Nicholas A Tritos; Amir H Hamrahian; Donna King; Susan L Greenspan; David M Cook; Peter J Jönsson; Maria Koltowska-Häggstrom; Beverly M K Biller
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-05       Impact factor: 3.478

4.  Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis.

Authors:  Nicholas A Tritos; Susan L Greenspan; Donna King; Amir Hamrahian; David M Cook; Peter J Jönsson; Michael P Wajnrajch; Maria Koltowska-Häggstrom; Beverly M K Biller
Journal:  J Clin Endocrinol Metab       Date:  2011-03-02       Impact factor: 5.958

5.  A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis.

Authors:  Nicholas A Tritos; Amir H Hamrahian; Donna King; Susan L Greenspan; David M Cook; Peter J Jönsson; Michael P Wajnrajch; Maria Koltowska-Häggstrom; Beverly M K Biller
Journal:  Eur J Endocrinol       Date:  2012-06-18       Impact factor: 6.664

6.  Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report.

Authors:  Eric R Braverman; Abdalla Bowirrat; Uma J Damle; Swetha Yeldandi; Thomas Jh Chen; Margaret Madigan; Mallory Kerner; Stanley X Huang; Stella Savarimuthu; Kenneth Blum
Journal:  J Med Case Rep       Date:  2010-09-15

7.  Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.

Authors:  S V Lim; M Marenzana; M Hopkinson; E O List; J J Kopchick; M Pereira; B Javaheri; J P Roux; P Chavassieux; M Korbonits; C Chenu
Journal:  Endocrinology       Date:  2015-02-03       Impact factor: 4.736

8.  Seven years of follow up of trabecular bone score, bone mineral density, body composition and quality of life in adults with growth hormone deficiency treated with rhGH replacement in a single center.

Authors:  Gonzalo Allo Miguel; Alicia Serraclara Plá; Myriam Lorena Partida Muñoz; Guillermo Martínez Díaz-Guerra; Federico Hawkins
Journal:  Ther Adv Endocrinol Metab       Date:  2016-04-13       Impact factor: 3.565

9.  Anti-osteopenic effect of alpha-ketoglutarate sodium salt in ovariectomized rats.

Authors:  Radoslaw Piotr Radzki; Marek Bienko; Stefan Grzegorz Pierzynowski
Journal:  J Bone Miner Metab       Date:  2012-08-03       Impact factor: 2.626

Review 10.  The consequences of chronic kidney disease on bone metabolism and growth in children.

Authors:  Justine Bacchetta; Jérôme Harambat; Pierre Cochat; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Nephrol Dial Transplant       Date:  2012-08       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.